Drug
Avatrombopag Maleate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Platelet Count Increased | 201 | 147.8 | 162.4 | signal |
| 2 | Platelet Count Decreased | 390 | 34.8 | 42.0 | signal |
| 3 | Petechiae | 16 | 14.6 | 14.7 | signal |
| 4 | Drug Effect Less Than Expected | 18 | 12.1 | 12.2 | signal |
| 5 | Gingival Bleeding | 15 | 10.4 | 10.4 | signal |
| 6 | Full Blood Count Abnormal | 8 | 7.2 | 7.2 | signal |
| 7 | Product Packaging Issue | 7 | 7.1 | 7.2 | signal |
| 8 | Product Prescribing Issue | 11 | 5.1 | 5.1 | signal |
| 9 | Laboratory Test Abnormal | 15 | 4.8 | 4.8 | signal |
| 10 | Hepatic Cirrhosis | 9 | 4.6 | 4.6 | signal |
| 11 | Intentional Dose Omission | 13 | 4.5 | 4.5 | signal |
| 12 | Deep Vein Thrombosis | 30 | 4.3 | 4.4 | signal |
| 13 | Inappropriate Schedule Of Product Administration | 81 | 4.3 | 4.5 | signal |
| 14 | Adverse Drug Reaction | 39 | 4.1 | 4.2 | signal |
| 15 | Hepatic Encephalopathy | 4 | 4.1 | 4.1 | signal |
| 16 | Leukaemia | 4 | 4.0 | 4.0 | signal |
| 17 | Pharyngeal Swelling | 4 | 4.0 | 4.0 | signal |
| 18 | Intentional Product Misuse | 36 | 3.9 | 4.0 | signal |
| 19 | Ear Discomfort | 4 | 3.7 | 3.7 | signal |
| 20 | Blood Count Abnormal | 6 | 3.7 | 3.7 | signal |
| 21 | Product Dose Omission Issue | 111 | 3.7 | 3.8 | signal |
| 22 | Product Use Complaint | 6 | 3.7 | 3.7 | signal |
| 23 | Blood Test Abnormal | 5 | 3.4 | 3.4 | signal |
| 24 | Myelodysplastic Syndrome | 5 | 3.3 | 3.3 | signal |
| 25 | Product Dose Omission In Error | 9 | 3.2 | 3.2 | signal |
| 26 | Emotional Disorder | 10 | 3.0 | 3.1 | signal |
| 27 | Eye Haemorrhage | 4 | 2.8 | 2.8 | no signal |
| 28 | Full Blood Count Decreased | 6 | 2.8 | 2.8 | signal |
| 29 | Haemorrhage | 30 | 2.7 | 2.7 | signal |
| 30 | Hepatocellular Injury | 4 | 2.7 | 2.7 | no signal |
| 31 | Pulmonary Thrombosis | 3 | 2.6 | 2.6 | no signal |
| 32 | Product Availability Issue | 5 | 2.1 | 2.1 | no signal |